Cargando…
Immunogenetics of new onset diabetes after transplantation in Kuwait
Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535099/ https://www.ncbi.nlm.nih.gov/pubmed/31190933 http://dx.doi.org/10.2147/DMSO.S195859 |
_version_ | 1783421543168081920 |
---|---|
author | Jahromi, Mohamed Al-Otaibi, Torki Othman, Nashwa Gheith, Osama Mahmoud, Tarek Nair, Prasad Halim, Medhat A Nampoory, Narayanam |
author_facet | Jahromi, Mohamed Al-Otaibi, Torki Othman, Nashwa Gheith, Osama Mahmoud, Tarek Nair, Prasad Halim, Medhat A Nampoory, Narayanam |
author_sort | Jahromi, Mohamed |
collection | PubMed |
description | Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified. We aimed to investigate NODAT among kidney transplant cohort in Kuwait with special stress on correlation between its risk factors and interferon gamma genotyping. Materials and methods: We surveyed 309 kidney transplant recipients from Hamed Al Essa Transplantation Centre, Kuwait. The participants were categorized into cohorts according to the development of NODAT diagnosed based on the American Diabetes Association guidelines. Statistical analyses were performed using SPSS software. We genotyped interferon gamma as the leading immunosignature for T lymphocyte. Results: No relationship between ethnicity and the development of NODAT was identified. However, there was a significant difference in age between cohorts. Younger patients demonstrated a lower rate of NODAT while, NODAT reached its maximum in 40–60-year age group. IFNG TT genotype was significantly associated with NODAT (p=0.005), while IFNG AA was considerably higher in the non-NODAT group. Conclusion: Beside the conventional contributing factors of NODAT, our results might represent a suitable platform for a larger cytokine and chemokine spectrum genotyping. |
format | Online Article Text |
id | pubmed-6535099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-65350992019-06-12 Immunogenetics of new onset diabetes after transplantation in Kuwait Jahromi, Mohamed Al-Otaibi, Torki Othman, Nashwa Gheith, Osama Mahmoud, Tarek Nair, Prasad Halim, Medhat A Nampoory, Narayanam Diabetes Metab Syndr Obes Original Research Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified. We aimed to investigate NODAT among kidney transplant cohort in Kuwait with special stress on correlation between its risk factors and interferon gamma genotyping. Materials and methods: We surveyed 309 kidney transplant recipients from Hamed Al Essa Transplantation Centre, Kuwait. The participants were categorized into cohorts according to the development of NODAT diagnosed based on the American Diabetes Association guidelines. Statistical analyses were performed using SPSS software. We genotyped interferon gamma as the leading immunosignature for T lymphocyte. Results: No relationship between ethnicity and the development of NODAT was identified. However, there was a significant difference in age between cohorts. Younger patients demonstrated a lower rate of NODAT while, NODAT reached its maximum in 40–60-year age group. IFNG TT genotype was significantly associated with NODAT (p=0.005), while IFNG AA was considerably higher in the non-NODAT group. Conclusion: Beside the conventional contributing factors of NODAT, our results might represent a suitable platform for a larger cytokine and chemokine spectrum genotyping. Dove 2019-05-20 /pmc/articles/PMC6535099/ /pubmed/31190933 http://dx.doi.org/10.2147/DMSO.S195859 Text en © 2019 Jahromi et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Jahromi, Mohamed Al-Otaibi, Torki Othman, Nashwa Gheith, Osama Mahmoud, Tarek Nair, Prasad Halim, Medhat A Nampoory, Narayanam Immunogenetics of new onset diabetes after transplantation in Kuwait |
title | Immunogenetics of new onset diabetes after transplantation in Kuwait |
title_full | Immunogenetics of new onset diabetes after transplantation in Kuwait |
title_fullStr | Immunogenetics of new onset diabetes after transplantation in Kuwait |
title_full_unstemmed | Immunogenetics of new onset diabetes after transplantation in Kuwait |
title_short | Immunogenetics of new onset diabetes after transplantation in Kuwait |
title_sort | immunogenetics of new onset diabetes after transplantation in kuwait |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535099/ https://www.ncbi.nlm.nih.gov/pubmed/31190933 http://dx.doi.org/10.2147/DMSO.S195859 |
work_keys_str_mv | AT jahromimohamed immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT alotaibitorki immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT othmannashwa immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT gheithosama immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT mahmoudtarek immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT nairprasad immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT halimmedhata immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait AT nampoorynarayanam immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait |